Professor Claude Wischik
Chair in Mental Health (Clin)
- About
-
- Email Address
- c.m.wischik@abdn.ac.uk
- Office Address
TauRx Therapeutics Ltd
1st Floor, Sir Moir Lockhead Building
395 King Street
Aberdeen
AB24 5RP
United Kingdom
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Research
-
Research Overview
Molecular Neuropathology of Alzheimer's Disease, and in particular the therapeutic intervention of tau pathology
- Publications
-
Page 12 of 12 Results 111 to 115 of 115
The molecular basis of tau protein pathology in Alzheimer's Disease and related neurodegenerative dementias
Neurobiology of Alzheimer’s Disease. Dawbarn, D., Allen, S. (eds.). 2 edition. Oxford University PressChapters in Books, Reports and Conference Proceedings: ChaptersStaging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease
American Journal of Pathology, vol. 157, no. 2, pp. 623-636Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S0002-9440(10)64573-7
α-Synuclein inclusions in Alzheimer and Lewy body diseases
Journal of Neuropathology and Experimental Neurology, vol. 59, no. 5, pp. 408-417Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1093/jnen/59.5.408
- [ONLINE] View publication in Scopus
alpha-synuclein inclusions in Alzheimer and Lewy body diseases
Journal of Neuropathology and Experimental Neurology, vol. 59, pp. 408-417Contributions to Journals: ArticlesThe extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old
Acta Neuropathologica, vol. 100, pp. 29-35Contributions to Journals: Articles